Literature DB >> 27934649

Safety and Effectiveness of Arginine in Adults.

Catherine J McNeal1, Cynthia J Meininger2, Deepika Reddy3, Colin D Wilborn4, Guoyao Wu5.   

Abstract

l-Arginine (Arg) appears to have a beneficial effect on the regulation of nutrient metabolism to enhance lean tissue deposition and on insulin resistance in humans. The observed safe level for oral administration of Arg is ∼20 g/d, but higher levels have been tested in short-term studies without serious adverse effects; however, more data are needed in both animal models and humans to fully evaluate safety as well as efficacy. The primary objective of this review is to summarize the current knowledge of the safety, pharmacokinetics, and effectiveness of oral Arg in adults. Arg supplementation has been used safely in vulnerable populations, such as pregnant women, preterm infants, and individuals with cystic fibrosis. Several recent studies have shown beneficial effects of Arg in individuals with obesity, insulin resistance, and diabetes. Collectively, the data suggest that Arg supplementation is a safe and generally well-tolerated nutriceutical that may improve metabolic profiles in humans.
© 2016 American Society for Nutrition.

Entities:  

Keywords:  adiposity; arginine; arginine pharmacokinetics; arginine safety; efficacy of arginine; insulin resistance

Mesh:

Substances:

Year:  2016        PMID: 27934649     DOI: 10.3945/jn.116.234740

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  10 in total

1.  Arginine refolds, stabilizes, and restores function of mutant pVHL proteins in animal model of the VHL cancer syndrome.

Authors:  Merav D Shmueli; Limor Levy-Kanfo; Esraa Haj; Alan R Schoenfeld; Ehud Gazit; Daniel Segal
Journal:  Oncogene       Date:  2018-09-07       Impact factor: 9.867

Review 2.  Perspective: L-arginine and L-citrulline Supplementation in Pregnancy: A Potential Strategy to Improve Birth Outcomes in Low-Resource Settings.

Authors:  Andrea M Weckman; Chloe R McDonald; Jo-Anna B Baxter; Wafaie W Fawzi; Andrea L Conroy; Kevin C Kain
Journal:  Adv Nutr       Date:  2019-09-01       Impact factor: 8.701

3.  Effect of l-Arginine Supplementation on Blood Pressure in Adults: A Systematic Review and Dose-Response Meta-analysis of Randomized Clinical Trials.

Authors:  Farideh Shiraseb; Omid Asbaghi; Reza Bagheri; Alexei Wong; Arturo Figueroa; Khadijeh Mirzaei
Journal:  Adv Nutr       Date:  2022-08-01       Impact factor: 11.567

4.  L-Arginine/nitric oxide regulates skeletal muscle development via muscle fibre-specific nitric oxide/mTOR pathway in chickens.

Authors:  Ruxia Wang; Kelin Li; Li Sun; Hongchao Jiao; Yunlei Zhou; Haifang Li; Xiaojuan Wang; Jingpeng Zhao; Hai Lin
Journal:  Anim Nutr       Date:  2022-05-02

5.  Protection of Cystinotic Mice by Kidney-Specific Megalin Ablation Supports an Endocytosis-Based Mechanism for Nephropathic Cystinosis Progression.

Authors:  Virginie Janssens; Héloïse P Gaide Chevronnay; Sandrine Marie; Marie-Françoise Vincent; Patrick Van Der Smissen; Nathalie Nevo; Seppo Vainio; Rikke Nielsen; Erik I Christensen; François Jouret; Corinne Antignac; Christophe E Pierreux; Pierre J Courtoy
Journal:  J Am Soc Nephrol       Date:  2019-09-23       Impact factor: 10.121

6.  Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans.

Authors:  Guoyao Wu; Cynthia J Meininger; Catherine J McNeal; Fuller W Bazer; J Marc Rhoads
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Arginase inhibition prevents the development of hypertension and improves insulin resistance in obese rats.

Authors:  Kelly J Peyton; Xiao-Ming Liu; Ahmad R Shebib; Fruzsina K Johnson; Robert A Johnson; William Durante
Journal:  Amino Acids       Date:  2018-04-27       Impact factor: 3.520

8.  Effects of acute arginine supplementation on neuroendocrine, metabolic, cardiovascular, and mood outcomes in younger men: A double-blind, placebo-controlled trial.

Authors:  John W Apolzan; Jesse A Stein; Jennifer C Rood; Robbie A Beyl; Shengping Yang; Frank L Greenway; Harris R Lieberman
Journal:  Nutrition       Date:  2022-03-20       Impact factor: 4.893

Review 9.  Hypercatabolism and Anti-catabolic Therapies in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome.

Authors:  Jinlin Zhang; Wenchen Luo; Changhong Miao; Jing Zhong
Journal:  Front Nutr       Date:  2022-07-13

Review 10.  Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences.

Authors:  Hanne Haahr; Tim Heise
Journal:  Clin Pharmacokinet       Date:  2020-02       Impact factor: 6.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.